…ognition and NeuroImaging in Neurodegenerative Disorders study (IRAS 250525/ NCT03861884) and encompassed demographic, clinical, cognitive test, cerebro…
All extracted funders
Showing 781–840 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
Articles mentioning funders
5,089 articles · page 304 of 425…In 2022, GIRFT (Getting It Right First Time, an NHS England programme to improve timeliness and quality of care) issued gui…
….com covering January-December 2023. All institutions providing NHS Cognitive Neurology Services were invited to participate. A com…
…ruko ® is a biosimilar to reference Natalizumab (NTZ)/Tysabri® (Biogen). It is a newer medication compared to reference NTZ, with less…
…ere assessed at a specialist inherited neuropathy centre or the NHS Highly Specialised Services for rare mitochondrial disorders. Eighteen genetically undiagno…
…ight while decreasing morning sleepiness upon awakening.Funding Idorsia Pharmaceuticals LtdOriginally presented at Sleep Europe 2024, Seville, Spain, P1213james.khoo…
… tumour referrals that present with a headache. We propose that NICE guidance may need further adaption, with stricter guidance to r…
… took regular clobazam before cannabidiol, 37 after, to satisfy NICE requirements for prescribing. Where not tolerated, minimal dose…
…Background The MHRA approved the subcutaneous (SC) injection of Ocrelizumab in July…
…ivered in the patients home, relieving pressure on overburdened NHS infusion centres and minimising loss of productivity for patien…
…ousands of children are set to be lifted out of poverty, as the UK government has announced that it will end the limit restricting universal …